Zhang T - Search Results

1

A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial.

Pal SK, Tangen C, Thompson IM Jr, Balzer-Haas N, George DJ, Heng DYC, Shuch B, Stein M, Tretiakova M, Humphrey P, Adeniran A, Narayan V, Bjarnason GA, Vaishampayan U, Alva A, Zhang T, Cole S, Plets M, Wright J, Lara PN Jr. Pal SK, et al. Among authors: zhang t. Lancet. 2021 Feb 20;397(10275):695-703. doi: 10.1016/S0140-6736(21)00152-5. Epub 2021 Feb 13. Lancet. 2021. PMID: 33592176 Free PMC article. Clinical Trial.

2

Enzalutamide versus abiraterone acetate for the treatment of men with metastatic castration-resistant prostate cancer.

Zhang T, Zhu J, George DJ, Armstrong AJ. Zhang T, et al. Expert Opin Pharmacother. 2015 Mar;16(4):473-85. doi: 10.1517/14656566.2015.995090. Epub 2014 Dec 23. Expert Opin Pharmacother. 2015. PMID: 25534660 Review.

3

Exploring the Clinical Benefit of Docetaxel or Enzalutamide After Disease Progression During Abiraterone Acetate and Prednisone Treatment in Men With Metastatic Castration-Resistant Prostate Cancer.

Zhang T, Dhawan MS, Healy P, George DJ, Harrison MR, Oldan J, Chin B, Armstrong AJ. Zhang T, et al. Clin Genitourin Cancer. 2015 Aug;13(4):392-399. doi: 10.1016/j.clgc.2015.01.004. Epub 2015 Jan 24. Clin Genitourin Cancer. 2015. PMID: 25708161

4

Development of a Novel c-MET-Based CTC Detection Platform.

Zhang T, Boominathan R, Foulk B, Rao C, Kemeny G, Strickler JH, Abbruzzese JL, Harrison MR, Hsu DS, Healy P, Li J, Pi C, Prendergast KM, Hobbs C, Gemberling S, George DJ, Hurwitz HI, Connelly M, Garcia-Blanco MA, Armstrong AJ. Zhang T, et al. Mol Cancer Res. 2016 Jun;14(6):539-47. doi: 10.1158/1541-7786.MCR-16-0011. Epub 2016 Mar 7. Mol Cancer Res. 2016. PMID: 26951228

5

Metastatic clear cell renal cell carcinoma: Circulating biomarkers to guide antiangiogenic and immune therapies.

Zhang T, Zhu J, George DJ, Nixon AB. Zhang T, et al. Urol Oncol. 2016 Nov;34(11):510-518. doi: 10.1016/j.urolonc.2016.06.020. Epub 2016 Aug 4. Urol Oncol. 2016. PMID: 27498927 Review.

6

Cabozantinib in genitourinary malignancies.

Zhang T, Park SE, Hong C, George DJ. Zhang T, et al. Future Oncol. 2017 Apr;13(8):755-765. doi: 10.2217/fon-2016-0358. Epub 2016 Nov 15. Future Oncol. 2017. PMID: 27842445 Review.

7

What is the role of sipuleucel-T in the treatment of patients with advanced prostate cancer? An update on the evidence.

Hu R, George DJ, Zhang T. Hu R, et al. Among authors: zhang t. Ther Adv Urol. 2016 Aug;8(4):272-278. doi: 10.1177/1756287216645314. Epub 2016 May 2. Ther Adv Urol. 2016. PMID: 27928429 Free PMC article. Review.

8

Prostate-specific antigen response in black and white patients treated with abiraterone acetate for metastatic castrate-resistant prostate cancer.

Ramalingam S, Humeniuk MS, Hu R, Rasmussen J, Healy P, Wu Y, Harrison MR, Armstrong AJ, George DJ, Zhang T. Ramalingam S, et al. Among authors: zhang t. Urol Oncol. 2017 Jun;35(6):418-424. doi: 10.1016/j.urolonc.2016.12.016. Epub 2017 Jan 23. Urol Oncol. 2017. PMID: 28126272

9

Systemic Therapy for Non-Clear Cell Renal Cell Carcinoma.

Zhang T, Gong J, Maia MC, Pal SK. Zhang T, et al. Am Soc Clin Oncol Educ Book. 2017;37:337-342. doi: 10.1200/EDBK_175572. Am Soc Clin Oncol Educ Book. 2017. PMID: 28561708 Free article.

10

Acute Myeloid Leukemia After Olaparib Treatment in Metastatic Castration-Resistant Prostate Cancer.

Zhu J, Tucker M, Wang E, Grossman JS, Armstrong AJ, George DJ, Zhang T. Zhu J, et al. Among authors: zhang t. Clin Genitourin Cancer. 2017 Dec;15(6):e1137-e1141. doi: 10.1016/j.clgc.2017.07.005. Epub 2017 Jul 14. Clin Genitourin Cancer. 2017. PMID: 28780018 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35,349 results

Search Page